EGFR Inhibitors for Lung Cancer and Forecast Market

List of Tables
Table 1. Key Players of EGFR Inhibitors for Lung Cancer in Global Market
Table 2. Top EGFR Inhibitors for Lung Cancer Players in Global Market, Ranking by Revenue (2024)
Table 3. Global EGFR Inhibitors for Lung Cancer Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global EGFR Inhibitors for Lung Cancer Revenue Share by Companies, 2020-2025
Table 5. Global EGFR Inhibitors for Lung Cancer Sales by Companies, (K Units), 2020-2025
Table 6. Global EGFR Inhibitors for Lung Cancer Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers EGFR Inhibitors for Lung Cancer Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers EGFR Inhibitors for Lung Cancer Product Type
Table 9. List of Global Tier 1 EGFR Inhibitors for Lung Cancer Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 EGFR Inhibitors for Lung Cancer Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global EGFR Inhibitors for Lung Cancer Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global EGFR Inhibitors for Lung Cancer Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global EGFR Inhibitors for Lung Cancer Sales (K Units), 2020-2025
Table 15. Segment by Type - Global EGFR Inhibitors for Lung Cancer Sales (K Units), 2026-2032
Table 16. Segment by Application � Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 21. By Region � Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 25. By Region - Global EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 26. By Country - North America EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 29. By Country - North America EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 30. By Country - Europe EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 33. By Country - Europe EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 34. By Region - Asia EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 37. By Region - Asia EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 38. By Country - South America EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 41. By Country - South America EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa EGFR Inhibitors for Lung Cancer Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa EGFR Inhibitors for Lung Cancer Sales, (K Units), 2026-2032
Table 46. Pfizer Company Summary
Table 47. Pfizer EGFR Inhibitors for Lung Cancer Product Offerings
Table 48. Pfizer EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Pfizer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca EGFR Inhibitors for Lung Cancer Product Offerings
Table 52. AstraZeneca EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Genentech (Roche Group) Company Summary
Table 55. Genentech (Roche Group) EGFR Inhibitors for Lung Cancer Product Offerings
Table 56. Genentech (Roche Group) EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Genentech (Roche Group) Key News & Latest Developments
Table 58. Beta Pharma Company Summary
Table 59. Beta Pharma EGFR Inhibitors for Lung Cancer Product Offerings
Table 60. Beta Pharma EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Beta Pharma Key News & Latest Developments
Table 62. Mylan Company Summary
Table 63. Mylan EGFR Inhibitors for Lung Cancer Product Offerings
Table 64. Mylan EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Mylan Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim EGFR Inhibitors for Lung Cancer Product Offerings
Table 68. Boehringer Ingelheim EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Teva Pharmaceuticals Company Summary
Table 71. Teva Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offerings
Table 72. Teva Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Teva Pharmaceuticals Key News & Latest Developments
Table 74. Qilu Pharmaceutical Company Summary
Table 75. Qilu Pharmaceutical EGFR Inhibitors for Lung Cancer Product Offerings
Table 76. Qilu Pharmaceutical EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Qilu Pharmaceutical Key News & Latest Developments
Table 78. Betta Pharmaceuticals Company Summary
Table 79. Betta Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offerings
Table 80. Betta Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Betta Pharmaceuticals Key News & Latest Developments
Table 82. Haosen Pharmaceutical Company Summary
Table 83. Haosen Pharmaceutical EGFR Inhibitors for Lung Cancer Product Offerings
Table 84. Haosen Pharmaceutical EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Haosen Pharmaceutical Key News & Latest Developments
Table 86. ARIAD Pharmaceuticals Company Summary
Table 87. ARIAD Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offerings
Table 88. ARIAD Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. ARIAD Pharmaceuticals Key News & Latest Developments
Table 90. HUTCHMED Company Summary
Table 91. HUTCHMED EGFR Inhibitors for Lung Cancer Product Offerings
Table 92. HUTCHMED EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. HUTCHMED Key News & Latest Developments
Table 94. Shanghai Ellis Company Summary
Table 95. Shanghai Ellis EGFR Inhibitors for Lung Cancer Product Offerings
Table 96. Shanghai Ellis EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Shanghai Ellis Key News & Latest Developments
Table 98. Genvio Pharma Company Summary
Table 99. Genvio Pharma EGFR Inhibitors for Lung Cancer Product Offerings
Table 100. Genvio Pharma EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Genvio Pharma Key News & Latest Developments
Table 102. Everest Pharmaceuticals Company Summary
Table 103. Everest Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offerings
Table 104. Everest Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Everest Pharmaceuticals Key News & Latest Developments
Table 106. Incepta Pharmaceuticals Company Summary
Table 107. Incepta Pharmaceuticals EGFR Inhibitors for Lung Cancer Product Offerings
Table 108. Incepta Pharmaceuticals EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Incepta Pharmaceuticals Key News & Latest Developments
Table 110. Jiangsu Hengrui Medicine Company Summary
Table 111. Jiangsu Hengrui Medicine EGFR Inhibitors for Lung Cancer Product Offerings
Table 112. Jiangsu Hengrui Medicine EGFR Inhibitors for Lung Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 114. EGFR Inhibitors for Lung Cancer Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 115. Global EGFR Inhibitors for Lung Cancer Capacity Market Share of Key Manufacturers, 2023-2025
Table 116. Global EGFR Inhibitors for Lung Cancer Production by Region, 2020-2025 (K Units)
Table 117. Global EGFR Inhibitors for Lung Cancer Production by Region, 2026-2032 (K Units)
Table 118. EGFR Inhibitors for Lung Cancer Market Opportunities & Trends in Global Market
Table 119. EGFR Inhibitors for Lung Cancer Market Drivers in Global Market
Table 120. EGFR Inhibitors for Lung Cancer Market Restraints in Global Market
Table 121. EGFR Inhibitors for Lung Cancer Raw Materials
Table 122. EGFR Inhibitors for Lung Cancer Raw Materials Suppliers in Global Market
Table 123. Typical EGFR Inhibitors for Lung Cancer Downstream
Table 124. EGFR Inhibitors for Lung Cancer Downstream Clients in Global Market
Table 125. EGFR Inhibitors for Lung Cancer Distributors and Sales Agents in Global Market


List of Figures
Figure 1. EGFR Inhibitors for Lung Cancer Product Picture
Figure 2. EGFR Inhibitors for Lung Cancer Segment by Type in 2024
Figure 3. EGFR Inhibitors for Lung Cancer Segment by Application in 2024
Figure 4. Global EGFR Inhibitors for Lung Cancer Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global EGFR Inhibitors for Lung Cancer Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global EGFR Inhibitors for Lung Cancer Revenue: 2020-2032 (US$, Mn)
Figure 8. EGFR Inhibitors for Lung Cancer Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by EGFR Inhibitors for Lung Cancer Revenue in 2024
Figure 10. Segment by Type � Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global EGFR Inhibitors for Lung Cancer Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global EGFR Inhibitors for Lung Cancer Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global EGFR Inhibitors for Lung Cancer Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global EGFR Inhibitors for Lung Cancer Price (US$/Unit), 2020-2032
Figure 18. By Region � Global EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 21. By Region - Global EGFR Inhibitors for Lung Cancer Sales Market Share, 2020-2032
Figure 22. By Country - North America EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 23. By Country - North America EGFR Inhibitors for Lung Cancer Sales Market Share, 2020-2032
Figure 24. United States EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 25. Canada EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 28. By Country - Europe EGFR Inhibitors for Lung Cancer Sales Market Share, 2020-2032
Figure 29. Germany EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 30. France EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 32. Italy EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 33. Russia EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 37. By Region - Asia EGFR Inhibitors for Lung Cancer Sales Market Share, 2020-2032
Figure 38. China EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 39. Japan EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 42. India EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America EGFR Inhibitors for Lung Cancer Revenue Market Share, 2020-2032
Figure 44. By Country - South America EGFR Inhibitors for Lung Cancer Sales, Market Share, 2020-2032
Figure 45. Brazil EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa EGFR Inhibitors for Lung Cancer Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa EGFR Inhibitors for Lung Cancer Sales, Market Share, 2020-2032
Figure 49. Turkey EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 50. Israel EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 52. UAE EGFR Inhibitors for Lung Cancer Revenue, (US$, Mn), 2020-2032
Figure 53. Global EGFR Inhibitors for Lung Cancer Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production EGFR Inhibitors for Lung Cancer by Region, 2024 VS 2032
Figure 55. EGFR Inhibitors for Lung Cancer Industry Value Chain
Figure 56. Marketing Channels